Nilza Karina Gonçalves

  • Monday, 12 November 2018 11:34

Nilza Karina

Identification

Nilza Karina, Researcher,
Master in Information Management (NOVA IMS|NOVA), PhD candidate in Information Management

Contacts

Telephone: +351213828610
Fax: +351213828 611
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Biography

Nilza Gonçalves is currently a doctoral student at NOVA Information Management School (NOVA IMS). She holds a degree in Social and Organizational Psychology from ISCTE (2000), a degree in Statistics and Information Management from NOVA Information Management School (2009) and a Master in Statistics and Information Management from the same institute. Her professional career has started in the area of Marketing Research as a consultant, moving later to the area of Clinical Research as a biostatistician where she is currently working. She is an invited lecturer in Faculty of Medicine of the University of Lisbon teaching a module in the discipline of Clinical Pharmacology and Therapeutics.

Publications

Book Section

  • Macedo,A., Gonçalves, N. Estatística Precisa-se! Edições Sílabo (2010).

Journal Article

  • Cardoso R, Guimarães I, Santos H, Loureiro R, Domingos J, Abreu D, Gonçalves N, Pinto S, Ferreira JJ. Psychosocial impact of Parkinson's disease-associated dysarthria: Cross-cultural adaptation and validation of the Dysarthria Impact Profile into European Portuguese. Geriatr Gerontol Int. 2018 May;18(5):767-774. doi: 10.1111/ggi.13255.
  • Fabbri M, Guimarães I, Cardoso R, Coelho M, Guedes LC, Rosa MM, Godinho C, Abreu D, Gonçalves N, Antonini A, Ferreira JJ. Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease. Front Neurol. 2017 Aug 22;8:432. doi: 10.3389/fneur.2017.00432.
  • Caldeira D, Rodrigues FB, Duarte MM, Sterrantino C, Barra M, Gonçalves N,Pinto FJ, Ferreira JJ, Costa J. Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis. Drug Saf. 2018 Jan;41(1):77-86. doi:10.1007/s40264-017-0586-2. Review.
  • Correia Guedes L, Reimão S, Paulino P, Nunes RG, Bouça-Machado R, Abreu D, Gonçalves N, Soares T, Fabbri M, Godinho C, Pita Lobo P, Neutel D, Quadri M, Coelho M, Rosa MM, Campos J, Outeiro TF, Sampaio C, Bonifati V, Ferreira JJ. Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease. Mov Disord. 2017 Sep;32(9):1331-1333. doi:10.1002/mds.27083. Epub 2017 Jul 7.
  • Fabbri M, Reimão S, Carvalho M, Nunes RG, Abreu D, Guedes LC, Bouça R, Lobo PP, Godinho C, Coelho M, Gonçalves NC, Rosa MM, Antonini A, Ferreira JJ. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease. J Parkinsons Dis. 2017;7(3):491-501. doi:10.3233/JPD-171135.
  • Rodrigues FB, Abreu D, Damásio J, Goncalves N, Correia-Guedes L, Coelho M, Ferreira JJ; REGISTRY Investigators of the European Huntington's Disease Network. Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort. Mov Disord Clin Pract. 2017 May 26;4(5):737-742. doi: 10.1002/mdc3.12502.
  • Fabbri M, Coelho M, Guedes LC, Rosa MM, Abreu D, Gonçalves N, Antonini A, Ferreira JJ. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease. Parkinsonism Relat Disord. 2017 Aug;41:113-117. doi: 10.1016/j.parkreldis.2017.05.003.
  • Cardoso R, Guimarães I, Santos H, Loureiro R, Domingos J, de Abreu D, Gonçalves N, Pinto S, Ferreira J. Frenchay dysarthria assessment (FDA-2) in Parkinson's disease: cross-cultural adaptation and psychometric properties of the European Portuguese version. J Neurol. 2017 Jan;264(1):21-31. doi: 10.1007/s00415-016-8298-6.
  • Godinho C, Domingos J, Cunha G, Santos AT, Fernandes RM, Abreu D, Gonçalves N, Matthews H, Isaacs T, Duffen J, Al-Jawad A, Larsen F, Serrano A, Weber P, Thoms A, Sollinger S, Graessner H, Maetzler W, Ferreira JJ. Erratum to: A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease. J Neuroeng Rehabil. 2016 Aug 1;13(1):71.
  • Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, Gonçalves N, Anderson KE, Cardoso F, Ferreira JJ, Mestre TA, Stout JC, Sampaio C. Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease. Mov Disord Clin Pract. 2016 Jun 22;4(2):212-224. doi: 10.1002/mdc3.12388.
  • Pinho R, Guedes LC, Soreq L, Lobo PP, Mestre T, Coelho M, Rosa MM, Gonçalves N, Wales P, Mendes T, Gerhardt E, Fahlbusch C, Bonifati V, Bonin M,Miltenberger-Miltényi G, Borovecki F, Soreq H, Ferreira JJ, F Outeiro T. GeneExpression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles. PLoS One. 2016 Jun 20;11(6):e0157852. doi: 10.1371/journal.pone.0157852. eCollection 2016. Erratum in: PLoS One. 2017 Dec28;12 (12 ):e0190552.
  • Godinho C, Domingos J, Cunha G, Santos AT, Fernandes RM, Abreu D, Gonçalves N, Matthews H, Isaacs T, Duffen J, Al-Jawad A, Larsen F, Serrano A, Weber P, Thoms A, Sollinger S, Graessner H, Maetzler W, Ferreira JJ. A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease. J Neuroeng Rehabil. 2016 Mar 12;13:24. doi: 10.1186/s12984-016-0136-7. Review. Erratum in: J Neuroeng Rehabil. 2016;13(1):71.
  • Reimão S, Pita Lobo P, Neutel D, Guedes LC, Coelho M, Rosa MM, Ferreira J, Abreu D, Gonçalves N, Morgado C, Nunes RG, Campos J, Ferreira JJ. Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease. J Parkinsons Dis. 2015;5(3):561-7. doi: 10.3233/JPD-150551.
  • Caldeira D, Gonçalves N, Ferreira JJ, Pinto FJ, Costa J. Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis. Am J Cardiovasc Drugs. 2015 Aug;15(4):259-65. doi: 10.1007/s40256-015-0132-5. Review.
  • Ferreira JJ, Godinho C, Santos AT, Domingos J, Abreu D, Lobo R, Gonçalves N, Barra M, Larsen F, Fagerbakke Ø, Akeren I, Wangen H, Serrano JA, Weber P, Thoms A, Meckler S, Sollinger S, van Uem J, Hobert MA, Maier KS, Matthew H, Isaacs T, Duffen J, Graessner H, Maetzler W. Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability study. BMC Neurol. 2015 Jun 10;15:89. doi: 10.1186/s12883-015-0343-z.
  • Caldeira D, Rodrigues FB, Barra M, Santos AT, de Abreu D, Gonçalves N, Pinto FJ, Ferreira JJ, Costa J. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. Heart. 2015 Aug;101(15):1204-11. doi: 10.1136/heartjnl-2015-307489.
  • Caldeira D, Gonçalves N, Pinto FJ, Costa J, Ferreira JJ. Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):757-64. doi: 10.1002/pds.3791.
  • Reimão S, Pita Lobo P, Neutel D, Guedes LC, Coelho M, Rosa MM, Azevedo P, Ferreira J, Abreu D, Gonçalves N, Nunes RG, Campos J, Ferreira JJ. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease. Mov Disord. 2015 Jun;30(7):953-9. doi: 10.1002/mds.26182.
  • Caldeira D, Barra M, Gonçalves N, Pinto FJ, Ferreira JJ, Costa J. Pericardial bleeding risk with non-vitamin K oral anticoagulants: a meta-analysis. Int J Cardiol. 2015 Mar 1;182:187-8. doi: 10.1016/j.ijcard.2014.12.062
  • Ferreira JJ, Gonçalves N, Valadas A, Januário C, Silva MR, Nogueira L, Vieira JLM, Lima AB. Prevalence of Parkinson's disease: a population-based study in Portugal. Eur J Neurol. 2017 May;24(5):748-750. doi: 10.1111/ene.13273. Mar 2.

Posters

  • Cunha-Miranda L, Fernandes S, Simões E, et al SAT0362 Quality of life and pain evaluation in patients with and without self-reported osteoporosis - corpo study: Comprehending osteoporosis real perception and overview. Annals of the Rheumatic Diseases 2013;71:594.
  • Cunha-Miranda L, Simões E, Fernandes S, et al SAT0363 Is there a before and after femoral neck fracture regarding quality of life? Corpo study: Comprehending osteoporosis real perception and overview Annals of the Rheumatic Diseases 2013;71:59
  • Gonçalves N, Ferreira J, de Abreu D, et al J23 Evaluation of Validity of UHDRS Translations in the Registry Study J Neurol Neurosurg Psychiatry 2014;85:A73.
  • N. Gonçalves, J. Mendes, J. Ferreira, C. Sampaio. Huntington’s Disease: Determinants for Cognitive Disease Progression – A Proposed Model [abstract]. Mov Disord. 2017; 32 (suppl 2).
Joana Lino
Written by 
Rate this item
(0 votes)
Read 1502 times Last modified on Thursday, 23 January 2020 10:15